| Dr Stephen Charles Stacey Jr, MD | |
|
660 Golden Ridge Rd, Suite 250, Golden, CO 80401-9541 | |
| (303) 233-1223 | |
| Not Available |
| Full Name | Dr Stephen Charles Stacey Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 14 Years |
| Location | 660 Golden Ridge Rd, Golden, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033439740 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MMD.32572LL (South Carolina) | Secondary |
| 207X00000X | Orthopaedic Surgery | DR.0054997 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Denver Health & Hospital Authority | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Denver Health And Hospital Authority | 4688583578 | 650 |
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
News Archive
About 90 percent of children with two copies of a common genetic variation and who wheezed when they caught a cold early in life went on to develop asthma by age 6, according to a study to be published March 28 by the New England Journal of Medicine.
A new study has shown that children in the United States are consuming too much added sugars and their daily intake exceeds the amounts recommended for adults.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
Health Affairs: Chronic Conditions Account For Rise In Medicare Spending From 1987 To 2006 - "Medicare beneficiaries' medical needs, and where beneficiaries undergo treatment, have changed dramatically over the past two decades." For example, the authors write, "heart disease ranked first among the top-ten conditions in terms of attributable share of growth from 1987 to 1997, accounting for nearly 14 percent of the increase in Medicare spending."
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.
› Verified 8 days ago
| Entity Name | Denver Health And Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211 |
News Archive
About 90 percent of children with two copies of a common genetic variation and who wheezed when they caught a cold early in life went on to develop asthma by age 6, according to a study to be published March 28 by the New England Journal of Medicine.
A new study has shown that children in the United States are consuming too much added sugars and their daily intake exceeds the amounts recommended for adults.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
Health Affairs: Chronic Conditions Account For Rise In Medicare Spending From 1987 To 2006 - "Medicare beneficiaries' medical needs, and where beneficiaries undergo treatment, have changed dramatically over the past two decades." For example, the authors write, "heart disease ranked first among the top-ten conditions in terms of attributable share of growth from 1987 to 1997, accounting for nearly 14 percent of the increase in Medicare spending."
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.
› Verified 8 days ago
| Entity Name | Panorama Orthopedics And Spine Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295787950 PECOS PAC ID: 8426961087 Enrollment ID: O20031110000424 |
News Archive
About 90 percent of children with two copies of a common genetic variation and who wheezed when they caught a cold early in life went on to develop asthma by age 6, according to a study to be published March 28 by the New England Journal of Medicine.
A new study has shown that children in the United States are consuming too much added sugars and their daily intake exceeds the amounts recommended for adults.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
Health Affairs: Chronic Conditions Account For Rise In Medicare Spending From 1987 To 2006 - "Medicare beneficiaries' medical needs, and where beneficiaries undergo treatment, have changed dramatically over the past two decades." For example, the authors write, "heart disease ranked first among the top-ten conditions in terms of attributable share of growth from 1987 to 1997, accounting for nearly 14 percent of the increase in Medicare spending."
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen Charles Stacey Jr, MD 660 Golden Ridge Rd, Suite 250, Golden, CO 80401-9541 Ph: () - | Dr Stephen Charles Stacey Jr, MD 660 Golden Ridge Rd, Suite 250, Golden, CO 80401-9541 Ph: (303) 233-1223 |
News Archive
About 90 percent of children with two copies of a common genetic variation and who wheezed when they caught a cold early in life went on to develop asthma by age 6, according to a study to be published March 28 by the New England Journal of Medicine.
A new study has shown that children in the United States are consuming too much added sugars and their daily intake exceeds the amounts recommended for adults.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
Health Affairs: Chronic Conditions Account For Rise In Medicare Spending From 1987 To 2006 - "Medicare beneficiaries' medical needs, and where beneficiaries undergo treatment, have changed dramatically over the past two decades." For example, the authors write, "heart disease ranked first among the top-ten conditions in terms of attributable share of growth from 1987 to 1997, accounting for nearly 14 percent of the increase in Medicare spending."
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.
› Verified 8 days ago
Charles A Gottlob, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd, Suite 250, Golden, CO 80401 Phone: 303-233-1223 Fax: 303-233-8755 | |
Raeburn M. Jenkins, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 660 Golden Ridge Road, Ste 250, Golden, CO 80401 Phone: 303-233-1223 Fax: 303-233-8755 | |
Dr. Lonnie E. Loutzenhiser, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd, Suite 250, Golden, CO 80401 Phone: 303-233-1223 Fax: 303-233-8755 | |
Dr. Sameer Jagan Lodha, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd, Ste. 250, Golden, CO 80401 Phone: 303-233-1223 Fax: 303-233-8755 | |
Douglas C Wong, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd, Suite 250, Golden, CO 80401 Phone: 303-233-1223 Fax: 303-233-8755 | |
Amit O Agarwala, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd, Ste 250, Golden, CO 80401 Phone: 303-233-1223 Fax: 303-233-8755 |